Breaking News Instant updates and real-time market news.

BCLI

BrainStorm

$3.89

0.17 (4.57%)

09:28
10/04/18
10/04
09:28
10/04/18
09:28

BrainStorm announces results from NurOwn Phase 2 trial

BrainStorm announced that their scientific abstract received the clinical abstract award at this year's Annual Northeast Amyotrophic Lateral Sclerosis, or NEALS, conference. To relate CSF miRNA changes to CSF biomarkers of apoptosis and innate immune activation in pre- and 2-weeks post-intrathecal transplantation of MSC-NTF cells in a NurOwn Phase 2 trial. The biomarker data demonstrated increases in miRNA 132 and miRNA 146a and statistically significant decreases in MCP-1, SDF-1, CHIT-1 and Caspase-3 levels in CSF following a single MSC-NTF cell transplantation in the NurOwn Phase 2 trial. The data presented suggests that miRNA secreted by MSC-NTF cells may contribute to CSF biomarker evidence of neuroprotection and immunomodulation. Additional miRNA evaluation and biomarker correlations will be examined in the ongoing NurOwn Phase 3 pivotal trial in ALS.

BCLI BrainStorm
$3.89

0.17 (4.57%)

06/26/18
HCWC
06/26/18
NO CHANGE
Target $11
HCWC
Buy
BrainStorm 'distressed' valuation an opportunity, says H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert noted that Brainstorm announced that it will not make NurOwn available under the newly enacted "Right to Try" Act. Management deemed this impractical since the unapproved ALS treatment would only be available to those who can afford it, which would be unethical. The focus must be on completing the clinical program so the therapy can be made available to all with reimbursement, said Kolbert, who thinks Brainstorm's current valuation is "distressed" at a market capitalization below $100M despite its lead program being in a pivotal trial. He maintains a Buy rating and $11 price target on Brainstorm shares.
05/15/18
HCWC
05/15/18
INITIATION
Target $11
HCWC
Buy
BrainStorm initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert initiated BrainStorm with a Buy and $11 price target saying it is developing a first of its kind cell therapy, called NurOwn, for the treatment of Amyotrophic Lateral Sclerosis, or ALS. Kolbert said NurOwn has an established clean safety profile and convenient dosing, but also has the potential to be disease modifying, slowing down disease progression. This, combined with orphan status for a 30K U.S. and 55K EU patient market, establish real value in the company.
12/28/17
MAXM
12/28/17
NO CHANGE
Target $9
MAXM
Buy
BrainStorm fundamentals remain intact despite stock weakness, says Maxim
Maxim analyst Jason Kolbert keeps his Buy rating and $9 price target on BrainStorm Cell, saying his recent conversations with the management indicate that the company fundamentals remain unchanged with no reason for the recent weakness in the stock price. Kolbert points to the company's interim Phase III analysis on safety of NurOwn expected in June.

TODAY'S FREE FLY STORIES

SLNG

Stabilis Energy

$5.01

0.24 (5.03%)

10:34
08/21/19
08/21
10:34
08/21/19
10:34
Conference/Events
Stabilis Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$101.73

16.16 (18.89%)

10:32
08/21/19
08/21
10:32
08/21/19
10:32
Upgrade
Target rating change at Wells Fargo »

Target upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

USO

United States Oil Fund

$11.79

0.15 (1.29%)

10:31
08/21/19
08/21
10:31
08/21/19
10:31
General news
Crude inventories for week of August 16 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.79

0.145 (1.25%)

10:30
08/21/19
08/21
10:30
08/21/19
10:30
Options
$5.8M straddle buy in US Oil ETF »

$5.8M straddle buy in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WW

WW

$28.25

0.01 (0.04%)

10:25
08/21/19
08/21
10:25
08/21/19
10:25
Options
Weight Watchers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/21/19
08/21
10:25
08/21/19
10:25
General news
Treasury Action: the slight beat in existing home sales didn't really impact »

Treasury Action: the…

10:20
08/21/19
08/21
10:20
08/21/19
10:20
General news
The U.S. July existing home sales report beat estimates »

The U.S. July existing…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOM

DMC Global

$42.78

1.375 (3.32%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Conference/Events
DMC Global management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/21/19
08/21
10:16
08/21/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.57

-2.29 (-4.42%)

10:15
08/21/19
08/21
10:15
08/21/19
10:15
Options
AFLAC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/21/19
08/21
10:15
08/21/19
10:15
General news
Breaking General news story  »

Week of 8/16 EIA…

HSGX

Histogenics

$0.22

0.0005 (0.23%)

10:14
08/21/19
08/21
10:14
08/21/19
10:14
Hot Stocks
Histogenics merger partner Ocugen granted FDA orphan designation »

Ocugen's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYCN

Cyclerion Therapeutics

$9.59

0.8 (9.10%)

10:12
08/21/19
08/21
10:12
08/21/19
10:12
Upgrade
Cyclerion Therapeutics rating change  »

Cyclerion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.65

-2.21 (-4.26%)

10:11
08/21/19
08/21
10:11
08/21/19
10:11
Recommendations
Aflac analyst commentary at Evercore ISI »

Aflac third sector sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLFD

Clearfield

$10.98

(0.00%)

, WSG

Wanda Sports

$4.12

0.22 (5.64%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

CLFD

Clearfield

$10.98

(0.00%)

WSG

Wanda Sports

$4.12

0.22 (5.64%)

INMB

INmune Bio

$6.30

0.46 (7.88%)

CLGX

CoreLogic

$47.28

0.49 (1.05%)

HUBB

Hubbell

$127.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 05

    Sep

  • 12

    Sep

  • 13

    Nov

CREE

Cree

$52.88

-5.31 (-9.13%)

, HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CREE

Cree

$52.88

-5.31 (-9.13%)

HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

CIM

Chimera

$19.52

-0.17 (-0.86%)

SYBX

Synlogic

$3.25

-0.22 (-6.34%)

JAZZ

Jazz Pharmaceuticals

$134.12

-2.42 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 30

    Oct

NOW

ServiceNow

$263.94

8.44 (3.30%)

, EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

NOW

ServiceNow

$263.94

8.44 (3.30%)

EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

PSA

Public Storage

$261.11

0.66 (0.25%)

LSI

Life Storage

$104.00

0.68 (0.66%)

ONDK

On Deck Capital

$3.26

0.025 (0.77%)

RDFN

Redfin

$18.28

0.83 (4.76%)

RMAX

RE/MAX Holdings

$27.38

0.71 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 18

    Sep

  • 27

    Oct

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar…

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
U.S. July existing home sales rebounded 2.5% to 5.420 M »

U.S. July existing home…

PFE

Pfizer

$34.96

0.34 (0.98%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
Pfizer announces additional half billion dollar investment for Sanford facility »

Pfizer announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

LKSD

LSC Communications

$1.34

0.01 (0.75%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
UBM acquires commingle operations from LSC Communications for $11.25M in cash »

LSC Communications and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
08/21/19
08/21
10:02
08/21/19
10:02
General news
Existing Home Sales data reported »

July Existing Home Sales…

HURN

Huron

$60.80

(0.00%)

10:02
08/21/19
08/21
10:02
08/21/19
10:02
Conference/Events
Huron management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

HURN

Huron

$60.80

(0.00%)

10:01
08/21/19
08/21
10:01
08/21/19
10:01
Conference/Events
Huron management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.